Development of a rapid profiling method for the analysis of polar analytes in urine using HILIC-MS and ion mobility enabled HILIC-MS.
Animals
Body Fluids
Chromatography, High Pressure Liquid
/ methods
Chromatography, Liquid
/ methods
High-Throughput Screening Assays
/ methods
Humans
Male
Metabolome
Metabolomics
/ methods
Quality Control
Rats
/ urine
Rats, Sprague-Dawley
/ urine
Reproducibility of Results
Tandem Mass Spectrometry
/ methods
Urine
/ chemistry
Hydrophilic interaction chromatography
IMS
LC–MS/MS
Metabolic phenotyping
Journal
Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889
Informations de publication
Date de publication:
22 01 2019
22 01 2019
Historique:
received:
07
08
2018
accepted:
20
12
2018
entrez:
5
3
2019
pubmed:
5
3
2019
medline:
24
3
2020
Statut:
epublish
Résumé
As large scale metabolic phenotyping is increasingly employed in preclinical studies and in the investigation of human health and disease the current LC-MS/MS profiling methodologies adopted for large sample sets can result in lengthy analysis times, putting strain on available resources. As a result of these pressures rapid methods of untargeted analysis may have value where large numbers of samples require screening. To develop, characterise and evaluate a rapid UHP-HILIC-MS-based method for the analysis of polar metabolites in rat urine and then extend the capabilities of this approach by the addition of IMS to the system. A rapid untargeted HILIC LC-MS/MS profiling method for the analysis of small polar molecules has been developed. The 3.3 min separation used a Waters BEH amide (1 mm ID) analytical column on a Waters Synapt G2-Si Q-Tof enabled with ion mobility spectrometry (IMS). The methodology, was applied to the metabolic profiling of a series of rodent urine samples from vehicle-treated control rats and animals administered tienilic acid. The same separation was subsequently linked to IMS and MS to evaluate the benefits that IMS might provide for metabolome characterisation. The rapid HILIC-MS method was successfully applied to rapid analysis of rat urine and found, based on the data generated from the data acquired for the pooled quality control samples analysed at regular intervals throughout the analysis, to be robust. Peak area and retention times for the compounds detected in these samples showed good reproducibility across the batch. When used to profile the urine samples obtained from vehicle-dosed control and those administered tienilic acid the HILIC-MS method detected 3007 mass/retention time features. Analysis of the same samples using HILIC-IMS-MS enabled the detection of 6711 features. Provisional metabolite identification for a number of compounds was performed using the high collision energy MS/MS information compared against the Metlin MS/MS database and, in addition, both calculated and measured CCS values from an experimentally derived CCS database. A rapid metabolic profiling method for the analysis of polar metabolites has been developed. The method has the advantages of speed and both reducing sample and solvent consumption compared to conventional profiling methods. The addition of IMS added an additional dimension for feature detection and the identification of metabolites.
Identifiants
pubmed: 30830424
doi: 10.1007/s11306-019-1474-9
pii: 10.1007/s11306-019-1474-9
pmc: PMC6342856
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17Références
Nat Protoc. 2011 Jun 30;6(7):1060-83
pubmed: 21720319
Am J Epidemiol. 2017 Nov 1;186(9):1084-1096
pubmed: 29106475
Anal Chem. 2016 Jun 7;88(11):5742-51
pubmed: 27116471
Nat Protoc. 2017 Apr;12(4):797-813
pubmed: 28301461
Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617
pubmed: 29140435
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Mar 5;817(1):67-76
pubmed: 15680789
Anal Chem. 2011 Nov 15;83(22):8703-10
pubmed: 21928819
Curr Opin Chem Biol. 2018 Feb;42:9-15
pubmed: 29107931
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):357-61
pubmed: 18502703
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jun 1;898:111-20
pubmed: 22608809
J Sep Sci. 2010 Mar;33(6-7):752-64
pubmed: 20183827
Metabolomics. 2015;11:9-26
pubmed: 25598764
Chem Res Toxicol. 2012 Nov 19;25(11):2412-22
pubmed: 23013248
Metabolomics. 2016;12:15
pubmed: 26617478
J Sep Sci. 2017 May;40(10):2198-2206
pubmed: 28371309
J Biosci Bioeng. 2013 Jul;116(1):9-16
pubmed: 23466298
Anal Chem. 2016 Nov 15;88(22):11084-11091
pubmed: 27768289
Mass Spectrom Rev. 2016 Sep;35(5):574-600
pubmed: 25284160
Anal Chem. 2016 Sep 20;88(18):9004-13
pubmed: 27479709
Anal Chim Acta. 2017 Aug 22;982:1-8
pubmed: 28734348
Mol Cell Proteomics. 2015 Jun;14(6):1684-95
pubmed: 25787789
Analyst. 2005 Jun;130(6):844-9
pubmed: 15912231
J Sep Sci. 2010 Mar;33(6-7):716-27
pubmed: 20187037
Chem Res Toxicol. 2012 Apr 16;25(4):895-903
pubmed: 22329513
Metabolomics. 2007 Sep;3(3):211-221
pubmed: 24039616
Curr Opin Chem Biol. 2018 Feb;42:60-66
pubmed: 29161611
Anal Chem. 2011 Jan 1;83(1):382-90
pubmed: 21142126
Bioanalysis. 2012 Sep;4(18):2249-64
pubmed: 23046267
Toxicol Pathol. 2008 Jan;36(1):140-7
pubmed: 18337232
Anal Chem. 2008 Aug 15;80(16):6382-9
pubmed: 18627180
J Sep Sci. 2008 May;31(9):1598-608
pubmed: 18461568
Anal Bioanal Chem. 2015 Jul;407(17):4995-5007
pubmed: 25893801
Pharmacogenomics. 2005 Oct;6(7):691-9
pubmed: 16207146
Curr Opin Chem Biol. 2018 Feb;42:42-50
pubmed: 29145156
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jun 15;1087-1088:142-148
pubmed: 29738964
Analyst. 2017 Aug 21;142(17):3079-3100
pubmed: 28792021
Metabolomics. 2016;12(11):173
pubmed: 27746707
Rapid Commun Mass Spectrom. 2001;15(12):986-93
pubmed: 11400208
Anal Chem. 2015 Jan 20;87(2):1137-44
pubmed: 25495617
Rapid Commun Mass Spectrom. 2013 Oct 15;27(19):2195-200
pubmed: 23996393